Antitussives

Ohio Becomes 21st State to Adopt Age-18 Sales Law for Cough Medicine

Retrieved on: 
Thursday, July 1, 2021

When used as directed, DXM is a safe and effective cough suppressant found in OTC cough and cold products.

Key Points: 
  • When used as directed, DXM is a safe and effective cough suppressant found in OTC cough and cold products.
  • CHPA thanks Governor DeWine for signing this important bill into law, as well as Representative Koehler for his tireless leadership on this issue, said Melville.
  • Smart public policy and education are both vitally important to combating teen OTC cough medicine abuse.
  • In 2012, California became the first state to prohibit sales of DXM-containing products to minors.

Insights on the Cough Syrup Global Market to 2027 - Opportunity Analysis and Industry Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 25, 2021

The "Cough Syrup Market by Product Type, Age Group and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cough Syrup Market by Product Type, Age Group and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global cough syrup market was valued at $5,232.73 million in 2019, and is projected to reach $6,108.25 million by 2027, registering a CAGR of 2.8% from 2020 to 2027.
  • The growth of the global cough syrup market is majorly driven by rise in respiratory disorders.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global cough syrup market.

Latin America, Middle East and Africa (LAMEA) Cough Syrup Market Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, May 24, 2021

Antitussives, which are also called cough suppressants, are majorly utilized to cure the symptoms of cough.

Key Points: 
  • Antitussives, which are also called cough suppressants, are majorly utilized to cure the symptoms of cough.
  • This cough suppressant helps in curing cough by decreasing the action of the cough reflex and decrease the urge to cough.
  • There are many people who use cough syrup to cure different types of cough.
  • The Cough Suppressants market dominated the Saudi Arabia Cough Syrup Market by Product in 2019, growing at a CAGR of 5.3 % during the forecast period.

North America Cough Syrup Market Report 2021: Increasing Cases of Respiratory Issues are Providing Lucrative Opportunities - Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 20, 2021

b'The "North America Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe increasing cases of respiratory issues are providing lucrative opportunities for the cough syrup market.

Key Points: 
  • b'The "North America Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe increasing cases of respiratory issues are providing lucrative opportunities for the cough syrup market.
  • Moreover, the rising population of old age people along with increasing air pollution are driving the growth of the market.
  • However, the misuse of cough syrup coupled with the strict rules & regulations by the government will restrict the market growth.
  • Moreover, the increasing disposable income of people in emerging nations will also contribute to the rising growth of the global cough syrups market.

Europe Cough Syrup Market Analysis and Forecast, 2020-2021 & Forecast to 2026 with Germany Dominating - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 20, 2021

b'The "Europe Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe Germany market dominated the Europe Pediatric Market by Country in 2019, growing at a CAGR of 5.7 % during the forecast period.

Key Points: 
  • b'The "Europe Cough Syrup Market By Product, By Age Group, By Distribution Channel, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe Germany market dominated the Europe Pediatric Market by Country in 2019, growing at a CAGR of 5.7 % during the forecast period.
  • In addition, the ever-growing enhancements in products are projected to provide new growth prospects for the cough syrup market.\nThe increasing cases of respiratory issues are providing lucrative opportunities for the cough syrup market.
  • However, the misuse of cough syrup coupled with the strict rules & regulations by the government will restrict the market growth.
  • On the other hand, the high market potential of the developing regions will garner more growth opportunities for the cough syrup market growth.\nThe Retail Pharmacy market dominated the Spain Cough Syrup Market by Distribution Channel in 2019, thereby, achieving a market value of $85.9 million by 2026.

National Survey Shows Slight Increase in Teen Abuse of OTC Cough Medicine

Retrieved on: 
Tuesday, December 15, 2020

The results of the 2020 National Institute on Drug Abuse (NIDA) and University of Michigans Monitoring the Future survey shows 3.7 percent of teens reported using over-the-counter (OTC) cough medicine containing dextromethorphan (DXM) to get high, an increase from 2.8 percent in 2019.

Key Points: 
  • The results of the 2020 National Institute on Drug Abuse (NIDA) and University of Michigans Monitoring the Future survey shows 3.7 percent of teens reported using over-the-counter (OTC) cough medicine containing dextromethorphan (DXM) to get high, an increase from 2.8 percent in 2019.
  • This years survey results underscore the importance of industrys commitment to preventing teen OTC cough medicine abuse, said Scott Melville, President and CEO, Consumer Healthcare Products Association (CHPA).
  • For years, CHPA has worked to help reduce teen DXM abuse by employing three strategies: increasing parent education and engagement in abuse awareness and prevention; heightening teen perceptions of the risks and social disapproval of medicine abuse; and, limiting teen access to DXM through age-18 sales restrictions in states.
  • In 2008, CHPA member companies took a major step in preventing abuse by voluntarily placing an icon on the packaging of OTC DXM products, encouraging parents to learn more about teen medicine abuse by visiting StopMedicineAbuse.org .

Advisory - Laboratoire Atlas Inc. is recalling one lot of "ATLAS - Codeine phosphate syrup 5 mg/mL" because some bottles contain isopropyl rubbing alcohol

Retrieved on: 
Thursday, October 29, 2020

One lot of ATLAS - Codeine phosphate syrup 5 mg/mL, manufactured by Laboratoire Atlas Inc., is being recalled because some bottles contain isopropyl rubbing alcohol 70% and not codeine syrup.

Key Points: 
  • One lot of ATLAS - Codeine phosphate syrup 5 mg/mL, manufactured by Laboratoire Atlas Inc., is being recalled because some bottles contain isopropyl rubbing alcohol 70% and not codeine syrup.
  • This is the result of a labelling error during the packaging process where Isopropyl rubbing alcohol products were mistakenly labelled as Codeine phosphate syrup 5 mg/mL.
  • All bottles from lot 35MC are being recalled as isopropyl rubbing alcohol is potentially toxic if ingested.
  • Contact patients who have been dispensed a prescription from this lot of codeine phosphate syrup 5 mg/mL by your pharmacy.

Robitussin Launches Their First-Ever Drug-Free Products for Cough Relief with a Cheerful Collaboration

Retrieved on: 
Wednesday, October 28, 2020

WARREN, N.J., Oct.28, 2020 /PRNewswire/ --GSK Consumer Healthcare (LSE/NYSE:GSK) today announced the launch of Robitussin Naturals, the brand's first-ever line of drug-free products that provide relief from occasional cough*.

Key Points: 
  • WARREN, N.J., Oct.28, 2020 /PRNewswire/ --GSK Consumer Healthcare (LSE/NYSE:GSK) today announced the launch of Robitussin Naturals, the brand's first-ever line of drug-free products that provide relief from occasional cough*.
  • Robitussin Naturals Cough Relief Syrup and Robitussin Naturals Cough Relief + Immune Health Syrup are the experts' in coughs first-of-their-kind, drug-free dietary supplements formulated with real True Source certified honey and English ivy to help relieve occasional coughs associated with hoarseness, dry throat or irritants*.
  • Robitussin Naturals Cough Relief Syrups and Gummies are available now at drugstores nationwide in varieties for both adults and children.
  • Robitussin is the #1 cough relief brand with more than 70 years of history providing consumers with powerful cough relief.

Nature Publication Highlights New ‘Blueprint’ Revealing How SARS-CoV-2 Hijacks Human Cells; Points to Drugs With Potential to Fight COVID-19 and a Drug That Aids Its Infectious Growth

Retrieved on: 
Thursday, April 30, 2020

One compound investigated in the research, a common ingredient in over-the-counter cough medicines, appears to have the potential to promote the growth of the virus.

Key Points: 
  • One compound investigated in the research, a common ingredient in over-the-counter cough medicines, appears to have the potential to promote the growth of the virus.
  • The researchers emphasized that while the drugs identified in the study are promising, they have only been tested against the virus in laboratory experiments.
  • The researchers do not advocate anyone prescribing and/or using the drugs unless human clinical trials find them to be safe and effective.
  • Two potent antihistamines, clemastine and cloperastine, displayed antiviral activity, as did PB28 and to a lesser extent the female hormone progesterone.

Codeine (CAS 76-57-3) Market Study, 2020: Global Applications, Manufacturers & Distributors, Prices, End-users and Downstream Sectors - ResearchAndMarkets.com

Retrieved on: 
Friday, March 27, 2020

The "Codeine (CAS 76-57-3) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Codeine (CAS 76-57-3) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Codeine.
  • The report helps to build up a clear view of the market trends and development, identify major players in the industry, and estimate main downstream sectors.
  • The Codeine global market report key points: